Tower Research Capital LLC (Trc) Jasper Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.42 - $0.93 $4,680 - $10,363	11,144 New	11,144 $8,000
Q2 2023 Aug 14, 2023	BUY	$1.19 - $1.79 $11,182 - $16,820	9,397 New	9,397 $12,000
Q4 2022 Feb 10, 2023	SELL	$0.46 - $8.9 $387 - $7,502	-843 Reduced 6.16%	12,839 $6,000
Q3 2022 Nov 10, 2022	BUY	$0.08 - $22.6 $725 - $205,004	9,071 Added 196.73%	13,682 $11,000
Q2 2022 Aug 15, 2022	BUY	$1.73 - $3.86 $5,632 - $12,568	3,256 Added 240.3%	4,611 $9,000
Q1 2022 May 12, 2022	SELL	$2.96 - $8.01 $4,614 - $12,487	-1,559 Reduced 53.5%	1,355 $5,000
Q4 2021 Feb 14, 2022	SELL	$7.21 - $16.42 $43,541 - $99,160	-6,039 Reduced 67.45%	2,914 $23,000
Q3 2021 Nov 15, 2021	BUY	$9.22 - $15.12 $82,546 - $135,369	8,953 New	8,953 $92,000

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $821M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.